Abstract
To analyze the effects of extracellular matrix metalloproteinase inducer (CD147) on glioma proliferation, apoptosis, invasion, and angiogenesis. Tissue samples were obtained from 101 glioma cases while normal brain tissues were obtained from 30 brain injury cases. Immunohistochemical assay was performed to detect the expressions of CD147, CD34, and VEGF in tissue samples. QRT-PCR was performed to detect the relative expression of CD147 mRNA in human glioma cell lines. CD147 siRNA was transfected into glioma cell line U251. Cell proliferation, apoptosis, invasion, and angiogenesis were tested by MTT, flow cytometry, Transwell assay, and vasculogenic mimicry assay, respectively. Expressions of relative proteins were analyzed with western blot. CD147 was positively expressed with the percentage of 0, 37.5, 44.8, 67.9, and 85.7 % in normal tissues and glioma tissues with WHO grades I–IV, respectively, and the scores of MVDand VEGF were associated with the expression of CD147. CD147 was significantly upregulated in the human glioma cell lines (P < 0.05). Downregulated the expression of CD147 suppressed cell proliferation, blocked cell cycle, induced apoptosis, inhibited cell invasion and angiogenesis in glioma cells in vitro. The expression of CD147 was significantly associated with WHO tumor grade and angiogenesis; silencing of CD147 contributed to inhibition of glioma proliferation, invasion, and angiogenesis. Our study provided firm evidence that CD 147 is a potential glioma target for anti-angiogenic therapies.
Similar content being viewed by others
References
Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Siegel R, Naishadham DandJemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
Ostrom QT et al (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncol 16:896–913
Louis DN et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820
Stupp R, Hegi MandWeller M (2010) Neuro-oncology, a decade of temozolomide and beyond. Expert Rev Anticancer Ther 10:1675–1677
Stupp R et al (2010) Phase i/iia study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J Clin Oncol Off J Am Soc Clin Oncol 28:2712–2718
Tate MC, Aghi MK (2009) Biology of angiogenesis and invasion in glioma. Neurother J Am Soc Exp Neurother 6:447–457
Cohen AL, Colman H (2015) Glioma biology and molecular markers. Cancer Treat Res 163:15–30
Zhao S et al (2013) Mir-106a is an independent prognostic marker in patients with glioblastoma. Neuro Oncol 15:707–717
Rosati A et al (2013) Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme. Neuro Oncol 15:618–625
Sun C et al (2013) Antisense mmp-9 rna inhibits malignant glioma cell growth in vitro and in vivo. Neurosci Bull 29:83–93
Gu J et al (2009) Clinical implications and prognostic value of emmprin/cd147 and mmp2 expression in pediatric gliomas. Eur J Pediatr 168:705–710
Yu XL et al (2008) Crystal structure of hab18 g/cd147: implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem 283:18056–18065
Weidle UH et al (2010) Cancer-related issues of cd147. Cancer Genom Proteom 7:157–169
Kanekura TandChen X (2010) Cd147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci 57:149–154
Tang Y et al (2004) Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (emmprin) expression and matrix metalloproteinase-dependent generation of soluble emmprin. Mol Cancer Res MCR 2:73–80
Zhong X et al (2013) Overexpressions of rack1 and cd147 associated with poor prognosis in stage t1 pulmonary adenocarcinoma. Ann Surg Oncol 20:1044–1052
Bi XC et al (2012) Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas. Clin Transl Oncol Off Publ Feder Spanish Oncol Soc Nat Cancer Inst Mexico 14:190–196
Piao S et al (2012) Increased expression of cd147 and mmp-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 138:627–635
Wen PY, Kesari S (2008) Malignant gliomas in adults. The New England journal of medicine 359:492–507
Stupp R et al (2010) High-grade malignant glioma: esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Euro Soc Med Oncol/ESMO 21(Suppl 5):v190–v193
Zhao P et al (2015) Gsk-3beta regulates tumor growth and angiogenesis in human glioma cells. Oncotarget 6:31901–31915
Chen L et al (2016) Upregulation of mir-107 inhibits glioma angiogenesis and vegf expression. Cell Mol Neurobiol 36:113–120
Fan Y et al (2014) Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through hif-1alpha accumulation. Nat Cell Biol 16:445–456
Vartanian A et al (2014) Gbm’s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro-Oncol 16:1167–1175
Van Meir EG et al (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193
Chu T et al (2011) Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. Pathol Oncol Res POR 17:705–711
Sameshima T et al (2000) Expression of emmprin (cd147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 88:21–27
Nabeshima K et al (2006) Emmprin (basigin/cd147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56:359–367
Liu F et al (2010) Expression of hab18 g is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat 124:677–688
Li Y et al (2012) Extracellular membrane-proximal domain of hab18 g/cd147 binds to metal ion-dependent adhesion site (midas) motif of integrin beta1 to modulate malignant properties of hepatoma cells. J Biol Chem 287:4759–4772
Liu Y et al (2013) Cd147, mmp9 expression and clinical significance of basal-like breast cancer. Med Oncol 30:366
Liang Q et al (2005) Inhibition of basigin expression in glioblastoma cell line via antisense rna reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 4:759–762
Miranda-Goncalves V et al (2013) Monocarboxylate transporters (mcts) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncol 15:172–188
Fei F et al (2015) The roles of cd147 in the progression of gliomas. Expert Rev Anticancer Ther 15:1351–1359
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yin, H., Shao, Y. & Chen, X. The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma. Neurol Sci 38, 129–136 (2017). https://doi.org/10.1007/s10072-016-2727-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2727-2